Results 251 to 260 of about 1,333,743 (274)

Antimicrobial Properties and Cytotoxicity of LL-37-Derived Synthetic Peptides to Treat Orthopedic Infections. [PDF]

Antibiotics (Basel)
Pennone V, Angelini E, Sarlah D, Lovati AB.   +3 more
europepmc   +1 more source

Salivary Cathelicidin (LL-37) in Children and Adolescents Living with HIV. [PDF]

Biomed Hub
Seminario AL, Karczewski AE, Chung W, Wang Y, Wamalwa D, Benki-Nugent S, John-Stewart G, Slyker JA, Kemoli A.   +8 more
europepmc   +1 more source

125 Psoriasin and LL-37 activate neutrophils

Japanese Journal of Allergology, 2006
openaire   +1 more source

RNA Selectively Modulates Activity of Virulent Amyloid PSMα3 and Host Defense LL-37 via Phase Separation and Aggregation Dynamics

Rayan B, Barnea E, Indig R, Pantoja CF, Gayk J, Lupu-Haber Y, Upcher A, Argoetti A, Aunstrup Larsen J, Buell AK, Zweckstetter M, Landau M.   +11 more
europepmc   +1 more source

Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses

bchm, 2009
Abstract Cathelicidins are effector molecules of the innate host defense system that establish an antimicrobial barrier at epithelial interfaces. The human cathelicidin LL-37, in addition to its antimicrobial activity, also exhibits immunomodulatory effects, such as inhibition of pro-inflammatory responses to bacterial LPS in human ...
Molhoek, E.M., den Hertog, A.L., de Vries, A.M.B.C., Nazmi, K., Veerman, E.C.I., Hartgers, F.C., Yazdanbakhsh, M., Bikker, F.J., van der Kleij, D.   +8 more
openaire   +7 more sources

LL-37 expression in the skin in systemic lupus erythematosus

Lupus, 2011
The objective of this study was to investigate the expression and relationship of LL-37, plasmacytoid dendritic cells (pDCs) and interferon-alpha (IFN-α) in skin in systemic lupus erythematosus (SLE), and their role in SLE pathogenesis. Skin biopsies were taken from nine SLE patients and six healthy volunteers.
C-L, Sun, F-Z, Zhang, P, Li, L-Q, Bi
openaire   +3 more sources

Cubosomes for topical delivery of the antimicrobial peptide LL-37

European Journal of Pharmaceutics and Biopharmaceutics, 2019
In this study, the use of cubosomes for topical delivery of the antimicrobial peptide (AMP) LL-37 was investigated. Topical delivery of AMPs is of great interest for treatment of skin infections caused by bacteria, such as Staphylococcus aureus. AMP containing cubosomes were produced by three different preparation protocols and compared: (i) pre ...
Lukas Boge, Karin Hallstensson, Lovisa Ringstad, Jenny Johansson, Therese Andersson, Mina Davoudi, Per Tomas Larsson, Margit Mahlapuu, Joakim Håkansson, Martin Andersson   +9 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

The chemistry and biology of LL-37

Natural Product Reports, 2009
LL-37 is a human host defence peptide that has a wide range of biological functions, including antimicrobial and immunomodulatory properties. This review summarises how molecular structure influences the balance between the immunomodulatory and antimicrobial functions of LL-37.
Matthew F, Burton, Patrick G, Steel
openaire   +2 more sources

Cathelicidin LL-37: A Multitask Antimicrobial Peptide

Archivum Immunologiae et Therapiae Experimentalis, 2010
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of ...
Robert, Bucki, Katarzyna, Leszczyńska, Andrzej, Namiot, Wojciech, Sokołowski   +3 more
openaire   +3 more sources